Skip to content

DOvEEgene: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics

Ovarian Neoplasms | Endometrial Neoplasms | Ovarian Cancer | Endometrial Cancer | Early Diagnosis | Safety |...

This study aims to develop and validate a test for diagnosing ovarian and endometrial cancers early. It relies on detecting somatic mutations that are associated with these cancers in a biofluids sample taken from the cervix and the uterine cavity.

null

Participation Requirements

  • Sex:

    FEMALE

  • Eligible Ages:

    18 and up

Participation Criteria

Case Inclusion:

* Subjects should have suspected or confirmed cancer of the upper genital tract.
* Participant will undergo surgery for tumour removal.

Control inclusion:

• Subjects should be scheduled to have a hysterectomy, bilateral salpingectomy, with or without bilateral oophorectomy, for presumed benign disease.

Study Location

Royal Victoria Hospital (Glen Site)
Royal Victoria Hospital (Glen Site)
Montreal, Quebec
Canada

Contact Study Team

Backup Contact

Dr. Claudia Martins, PhD

[email protected]
(514)934-1934
Primary Contact

Dr. Lucy Gilbert, MD,MSc,FRCOG

[email protected]
(514)934-1934
Jewish General Hospital
Jewish General Hospital
Montreal, Quebec
Canada

Contact Study Team

Study Sponsored By
McGill University
Participants Required
More Information
Study ID: NCT02288676